IRISYS LLC

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AzurRx Will Take First Wave Name After

Not surprisingly, many Japanese development-stage ventures tend to be heavily reliant on the domestic market and sources of funding, but two firms have recently made moves to expand their horizons, wi